CDC: Physicians should confirm patients’ penicillin allergies

New research from the U.S. Center for Disease Control and Prevention (CDC) points to evidence that many patients who claim they have a penicillin allergy may actually not have one.

Right now, about 30 million people would say they are allergic to penicillin, which can be dangerous when physicians are looking for alternative antibiotics to give them. Some of those alternative medications can be more toxic and carry higher rates of infections and morbidity.

The CDC is suggesting that physicians evaluate patients who say they have a penicillin allergy, which is about 10 percent of U.S. hospital patients, and test to see if they really have it. Studies show that less than 1 percent of Americans are allergic to penicillin.

"Some patients who report penicillin allergies may never have had true allergies,” said CDC epidemiologist Katherine Fleming-Dutra, MD, in a statement. “They may have had side effects or a symptom of the underlying illness that was interpreted as an allergy, such as a viral exanthema or rash in a child on amoxicillin.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup